Summary
In June, the Centers for Medicare & Medicaid Services released is much-anticipated proposal to offer “transitional coverage for emerging technologies.” The rule purports to offer an expedited pathway to Medicare coverage for certain medical devices. On July 27th, Matt Wetzel, Partner, Life Sciences, at Goodwin Procter hosted a webinar to break down the so-called TCET rule and what it means for medical technology companies with breakthrough designation.
Speakers
- /en/people/w/wetzel-matt
Matt Wetzel
PartnerLife Sciences Regulatory & Compliance